Literature DB >> 19169496

Association between 894G>T endothelial nitric oxide synthase gene polymorphisms and metabolic syndrome.

Jacqueline C Escobar Piccoli1, Maria Gabriela Valle Gottlieb, Luciano Castro, Luiz Carlos Bodanese, Euler Roberto Fernandes Manenti, Mauricio Reis Bogo, Alessandra Peres, Maria Izabel U M da Rocha, Ivana Beatrice Mânica da Cruz.   

Abstract

Metabolic syndrome (MS) is a cluster of cardiovascular risk factors such as hypertension, dyslipidemia, obesity and type II diabetes. Here, we performed a case-control study analyzing the association between 894G>T endothelial nitric oxide synthase gene polymorphism (NOS3) and MS in 616 subjects. Genotype frequencies were TT= 9.3%, GG= 37.2 and TG= 53.6% and the allelic frequencies were T=0.36 and G= 0.64. We observed a higher TT genotype frequency in the male MS group than control subjects (p=0.02), independent of other variables. We found an association between hypertension and TT genotype in females. Our data suggests that 894G>T plays a significant role in the mechanistic interaction between metabolic risk such as hypertension and MS, although sex-related differences may exist.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19169496     DOI: 10.1590/s0004-27302008000800027

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  11 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

Review 2.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

3.  Univariate and bivariate linkage analysis identifies pleiotropic loci underlying lipid levels and type 2 diabetes risk.

Authors:  Sandra J Hasstedt; Craig L Hanis; Steven C Elbein
Journal:  Ann Hum Genet       Date:  2010-07       Impact factor: 1.670

Review 4.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

Review 5.  Metabolic and infectious pathologies in Brazilian medical literature: a review.

Authors:  Mauricio Rocha-e-Silva
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 6.  Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Stephanie J Sheppard; Raouf A Khalil
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-03

7.  Nitric oxide system and diabetic nephropathy.

Authors:  Bruno Schmidt Dellamea; Cristiane Bauermann Leitão; Rogério Friedman; Luis Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2014-02-12       Impact factor: 3.320

8.  Ancient DNA reveals selection acting on genes associated with hypoxia response in pre-Columbian Peruvian Highlanders in the last 8500 years.

Authors:  Lars Fehren-Schmitz; Lea Georges
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

9.  Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients.

Authors:  Nikolai Fattakhov; Liudmila Smirnova; Dmitriy Atochin; Daria Parshukova; Daria Skuratovskaia; Quinn Painter; Pavel Zatolokin; Arkadiy Semke; Larisa Litvinova; Svetlana Ivanova
Journal:  Int J Obes (Lond)       Date:  2018-06-15       Impact factor: 5.095

10.  Endothelial nitric oxide synthase gene (T786C and G894T) polymorphisms in Egyptian patients with type 2 diabetes.

Authors:  Omneya Moguib; Hala M Raslan; Inas Abdel Rasheed; Laila Effat; Nadia Mohamed; Safaa El Serougy; Ghada Hussein; Salwa Tawfeek; Amany H AbdelRahman; Khalda Omar
Journal:  J Genet Eng Biotechnol       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.